Giant Congenital Melanocytic Nevus (GCMN)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) The patients or their legal representatives have given written informed consent. 2) The patients to whom J-TEC-01 have been transplanted in the clinical study (protocol No. 3SI-GCMN001).
Exclusion criteria
Exclusion criteria: 1) The patients who are participating or will participate in other clinical studies. 2) The patients who are considered ineligible by the principal investigator or subinvestigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| State of the grafted site after complete epithelialization; incidence rates of adverse event and failure; safety | — |
Countries
Japan
Contacts
Japan Tissue Engineering Co.,Ltd Clinical Development Dept.